GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Biocryst Pharmaceuticals, Inc. (BCRX) [hlAlert]

Rating:
Buy BCRX
down 3.69 %

Biocryst Pharmaceuticals, Inc. (BCRX) rated Buy with price target $18 by ROTH Capital

Posted on: Tuesday,  Jan 21, 2014  8:25 AM ET by Roth Capital

Roth Capital rated Buy Biocryst Pharmaceuticals, Inc. (NASDAQ: BCRX) on 01/21/2014, when the stock price was $11.64. Since
then, Biocryst Pharmaceuticals, Inc. has lost 3.69% as of 01/25/2016's recent price of $11.21.
If you would have followed this Roth Capital's recommendation on BCRX, you would have lost 3.69% of your investment in 734 days.

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/21/2014 8:25 AM Buy
None
11.64 18.00
as of 10/17/2014
1 Week up  11.02 %
1 Month up  2.47 %
3 Months up  8.12 %
1 YTD down  -0.51 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy